As of 2026-10-04, the Relative Valuation of Karyopharm Therapeutics Inc (KPTI) is (58.18) USD. This relative valuation is based on P/E multiples. With the latest stock price at 0.80 USD, the upside of Karyopharm Therapeutics Inc based on Relative Valuation is -7352.6%.
The range of the Relative Valuation is (38.26) - (87.85) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 3.7x - 19.2x | 10.8x |
| Forward P/E multiples | 7.3x - 16.8x | 11.4x |
| Fair Price | (38.26) - (87.85) | (58.18) |
| Upside | -4869.7% - -11050.7% | -7352.6% |
| Date | P/E |
| 2026-10-02 | -0.15 |
| 2026-10-01 | -0.17 |
| 2026-09-30 | -0.23 |
| 2026-09-29 | -0.23 |
| 2026-09-28 | -0.31 |
| 2026-09-25 | -0.31 |
| 2026-09-24 | -0.33 |
| 2026-09-23 | -0.33 |
| 2026-09-22 | -0.35 |
| 2026-09-21 | -0.35 |
| 2026-09-18 | -0.36 |
| 2026-09-17 | -0.34 |
| 2026-09-16 | -0.32 |
| 2026-09-15 | -0.29 |
| 2026-09-14 | -0.31 |
| 2026-09-11 | -0.31 |
| 2026-09-10 | -0.31 |
| 2026-09-09 | -0.32 |
| 2026-09-08 | -0.33 |
| 2026-09-04 | -0.34 |
| 2026-09-03 | -0.34 |
| 2026-09-02 | -0.34 |
| 2026-09-01 | -0.35 |
| 2026-08-31 | -0.39 |
| 2026-08-28 | -0.36 |
| 2026-08-27 | -0.37 |
| 2026-08-26 | -0.37 |
| 2026-08-25 | -0.37 |
| 2026-08-24 | -0.35 |
| 2026-08-21 | -0.37 |
| 2026-08-20 | -0.35 |
| 2026-08-19 | -0.38 |
| 2026-08-18 | -0.37 |
| 2026-08-17 | -0.35 |
| 2026-08-14 | -0.39 |
| 2026-08-13 | -0.38 |
| 2026-08-12 | -0.39 |
| 2026-08-11 | -0.40 |
| 2026-08-10 | -0.37 |
| 2026-08-07 | -0.40 |
| 2026-08-06 | -0.37 |
| 2026-08-05 | -0.36 |
| 2026-08-04 | -0.37 |
| 2026-08-03 | -0.38 |
| 2026-07-31 | -0.37 |
| 2026-07-30 | -1.34 |
| 2026-07-29 | -1.31 |
| 2026-07-28 | -1.35 |
| 2026-07-27 | -1.35 |
| 2026-07-24 | -1.41 |